<?xml version='1.0' encoding='UTF-8'?><!DOCTYPE collection SYSTEM 'BioC.dtd'><collection><source>PubTator</source><date></date><key>BioC.key</key><document><id>10027390</id><passage><infon key="journal">Am. J. Pathol.; 1999 Feb; 154(2) 325-9</infon><infon key="year">1999</infon><infon key="article-id_pmc">PMC1850000</infon><infon key="type">title</infon><infon key="authors">Rimm DL, Caca K, Hu G, Harrison FB, Fearon ER</infon><offset>0</offset><text>Frequent nuclear/cytoplasmic localization of beta-catenin without exon 3 mutations in malignant melanoma.</text><annotation id="2"><infon key="identifier">1499</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">1434</infon><location offset="45" length="12"/><text>beta-catenin</text></annotation><annotation id="3"><infon key="identifier">MESH:D008545</infon><infon key="type">Disease</infon><location offset="86" length="18"/><text>malignant melanoma</text></annotation></passage><passage><infon key="type">abstract</infon><offset>106</offset><text>Beta-Catenin has a critical role in E-cadherin-mediated cell-cell adhesion, and it also functions as a downstream signaling molecule in the wnt pathway. Mutations in the putative glycogen synthase kinase 3beta phosphorylation sites near the beta-catenin amino terminus have been found in some cancers and cancer cell lines. The mutations render beta-catenin resistant to regulation by a complex containing the glycogen synthase kinase 3beta, adenomatous polyposis coli, and axin proteins. As a result, beta-catenin accumulates in the cytosol and nucleus and activates T-cell factor/ lymphoid enhancing factor transcription factors. Previously, 6 of 27 melanoma cell lines were found to have beta-catenin exon 3 mutations affecting the N-terminal phosphorylation sites (Rubinfeld B, Robbins P, Elgamil M, Albert I, Porfiri E, Polakis P: Stabilization of beta-catenin by genetic defects in melanoma cell lines. Science 1997, 275:1790-1792). To assess the role of beta-catenin defects in primary melanomas, we undertook immunohistochemical and DNA sequencing studies in 65 melanoma specimens. Nuclear and/or cytoplasmic localization of beta-catenin, a potential indicator of wnt pathway activation, was seen focally within roughly one third of the tumors, though a clonal somatic mutation in beta-catenin was found in only one case (codon 45 Ser--&amp;gt;Pro). Our findings demonstrate that beta-catenin mutations are rare in primary melanoma, in contrast to the situation in melanoma cell lines. Nonetheless, activation of beta-catenin, as indicated by its nuclear and/or cytoplasmic localization, appears to be frequent in melanoma, and in some cases, it may reflect focal and transient activation of the wnt pathway within the tumor.</text><annotation id="32"><infon key="identifier">1499</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">1434</infon><location offset="106" length="12"/><text>Beta-Catenin</text></annotation><annotation id="33"><infon key="identifier">999</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">20917</infon><location offset="142" length="10"/><text>E-cadherin</text></annotation><annotation id="34"><infon key="identifier">1499</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">1434</infon><location offset="347" length="12"/><text>beta-catenin</text></annotation><annotation id="35"><infon key="identifier">MESH:D009369</infon><infon key="type">Disease</infon><location offset="399" length="7"/><text>cancers</text></annotation><annotation id="36"><infon key="identifier">MESH:D009369</infon><infon key="type">Disease</infon><location offset="411" length="6"/><text>cancer</text></annotation><annotation id="37"><infon key="identifier">1499</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">1434</infon><location offset="451" length="12"/><text>beta-catenin</text></annotation><annotation id="38"><infon key="identifier">MESH:D011125</infon><infon key="type">Disease</infon><location offset="548" length="26"/><text>adenomatous polyposis coli</text></annotation><annotation id="39"><infon key="identifier">8312</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">2614</infon><location offset="580" length="4"/><text>axin</text></annotation><annotation id="40"><infon key="identifier">1499</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">1434</infon><location offset="608" length="12"/><text>beta-catenin</text></annotation><annotation id="41"><infon key="identifier">MESH:D008223</infon><infon key="type">Disease</infon><location offset="689" length="8"/><text>lymphoid</text></annotation><annotation id="42"><infon key="identifier">MESH:D008545</infon><infon key="type">Disease</infon><location offset="758" length="8"/><text>melanoma</text></annotation><annotation id="43"><infon key="identifier">1499</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">1434</infon><location offset="797" length="12"/><text>beta-catenin</text></annotation><annotation id="44"><infon key="identifier">1499</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">1434</infon><location offset="959" length="12"/><text>beta-catenin</text></annotation><annotation id="45"><infon key="identifier">MESH:D030342</infon><infon key="type">Disease</infon><location offset="975" length="15"/><text>genetic defects</text></annotation><annotation id="46"><infon key="identifier">MESH:D008545</infon><infon key="type">Disease</infon><location offset="994" length="8"/><text>melanoma</text></annotation><annotation id="47"><infon key="identifier">1499</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">1434</infon><location offset="1067" length="12"/><text>beta-catenin</text></annotation><annotation id="48"><infon key="identifier">MESH:D008545</infon><infon key="type">Disease</infon><location offset="1091" length="17"/><text>primary melanomas</text></annotation><annotation id="49"><infon key="identifier">MESH:D008545</infon><infon key="type">Disease</infon><location offset="1176" length="8"/><text>melanoma</text></annotation><annotation id="50"><infon key="identifier">1499</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">1434</infon><location offset="1239" length="12"/><text>beta-catenin</text></annotation><annotation id="51"><infon key="identifier">MESH:D009369</infon><infon key="type">Disease</infon><location offset="1351" length="6"/><text>tumors</text></annotation><annotation id="52"><infon key="identifier">1499</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">1434</infon><location offset="1395" length="12"/><text>beta-catenin</text></annotation><annotation id="53"><infon key="identifier">MESH:D012694</infon><infon key="type">Chemical</infon><location offset="1445" length="3"/><text>Ser</text></annotation><annotation id="54"><infon key="identifier">1499</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">1434</infon><location offset="1490" length="12"/><text>beta-catenin</text></annotation><annotation id="55"><infon key="identifier">MESH:D008545</infon><infon key="type">Disease</infon><location offset="1525" length="16"/><text>primary melanoma</text></annotation><annotation id="56"><infon key="identifier">MESH:D008545</infon><infon key="type">Disease</infon><location offset="1575" length="8"/><text>melanoma</text></annotation><annotation id="57"><infon key="identifier">1499</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">1434</infon><location offset="1623" length="12"/><text>beta-catenin</text></annotation><annotation id="58"><infon key="identifier">MESH:D008545</infon><infon key="type">Disease</infon><location offset="1724" length="8"/><text>melanoma</text></annotation><annotation id="59"><infon key="identifier">MESH:D009369</infon><infon key="type">Disease</infon><location offset="1829" length="5"/><text>tumor</text></annotation></passage></document></collection>